
ANTONAZZO IPPAZIO COSIMO
Pubblicazioni
Antonazzo, I., Rozza, D., Cortesi, P., Fornari, C., Zanzottera Ferrari, E., Paris, C., et al. (2025). Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database. ACTA DIABETOLOGICA, 62(3), 343-351 [10.1007/s00592-024-02359-1]. Dettaglio
Ferrara, P., Monti, C., Rozza, D., Fornari, C., Antonazzo, I., Ferrara, M., et al. (2025). Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 37(1) [10.1007/s40520-025-03111-7]. Dettaglio
Losa, L., Antonazzo, I., Di Martino, G., Mazzaglia, G., Tafuri, S., Mantovani, L., et al. (2024). Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression. VACCINES, 12(5) [10.3390/vaccines12050527]. Dettaglio
Antonazzo, I., Gribaudo, G., La Vecchia, A., Ferrara, P., Piraino, A., Cortesi, P., et al. (2024). Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review. PHARMACOECONOMICS, 42(12), 1329-1343 [10.1007/s40273-024-01428-1]. Dettaglio
Ponticelli, D., Antonazzo, I., Losa, L., Zampella, A., Di Marino, F., Mottola, G., et al. (2024). Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy. MEDICINA, 60(1) [10.3390/medicina60010093]. Dettaglio